Related references
Note: Only part of the references are listed.Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
Yao Dai et al.
ACTA DIABETOLOGICA (2013)
Cardioprotective Effects of Exenatide in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Results of Exenatide Myocardial Protection in Revascularization Study
Jong Shin Woo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
The Emerging Role of Dipeptidyl Peptidase-4 Inhibitors in Cardiovascular Protection: Current Position and Perspectives
Xi-Mei Wang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials
Pitchai Balakumar et al.
CELLULAR SIGNALLING (2013)
Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity
I. Ray Mohanty et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2013)
Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta
Mojca Lunder et al.
HEART AND VESSELS (2013)
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
Kroekkiat Chinda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Variable effects of anti-diabetic drugs in animal models of myocardial ischemia and remodeling: A translational perspective for the cardiologist
Meimei Yin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction
Hans D. Theiss et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cardiovascular effects of gliptins
Andre J. Scheen
NATURE REVIEWS CARDIOLOGY (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dipeptidyl Peptidase-4 Inhibitors and Their Effects on the Cardiovascular System
B. Solun et al.
CURRENT CARDIOLOGY REPORTS (2013)
Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
Yochai Birnbaum et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Exenatide Reduces Final Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction and Short-Duration of Ischemia
Jacob Lonborg et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Cardioprotective effects of incretin during ischaemia-reperfusion
Kroekkiat Chinda et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
Exenatide Exerts a Potent Antiinflammatory Effect
Ajay Chaudhuri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury
Yumei Ye et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats
Barbara Huisamen et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Atorvastatin Protects against Ischemia-Reperfusion Injury in Fructose-Induced Insulin Resistant Rats
Prem Prakash et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
The Anti-Ischemic and Anti-Anginal Properties of Statins
Joel A. Lardizabal et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size
Hakan Parlakpinar et al.
CYTOKINE (2011)
Cardiovascular Effects of Glucagon-Like Peptide 1
A. Papazafiropoulou et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
Gian Paolo Fadini et al.
VASCULAR PHARMACOLOGY (2011)
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
Derek J. Hausenloy et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Postconditioning and protection from reperfusion injury: where do we stand?Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
Michel Ovize et al.
CARDIOVASCULAR RESEARCH (2010)
Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
Meghan Sauve et al.
DIABETES (2010)
The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes Possible role of stromal-derived factor-1α
Gian Paolo Fadini et al.
DIABETES CARE (2010)
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
Germano Di Sciascio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment - A potential role for phosphatase and tensin homolog deleted on chromosome ten?
K Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
